Literature DB >> 7969286

Prevention of nephrotoxicity induced by radiocontrast agents.

B J Barrett, P S Parfrey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7969286     DOI： 10.1056/NEJM199411243312111

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  31 in total

1.  Prevention of contrast-induced acute kidney injury by theophylline in elderly patients with chronic kidney disease.

Authors:  Jan Matejka; Ivo Varvarovsky; Petr Vojtisek; Ales Herman; Vladimir Rozsival; Veronika Borkova; Jiri Kvasnicka
Journal:  Heart Vessels       Date:  2010-09-29       Impact factor: 2.037

2.  Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug.

Authors:  Farahnak Assadi
Journal:  Pediatr Cardiol       Date:  2006 Mar-Apr       Impact factor: 1.655

Review 3.  Contrast nephropathy.

Authors:  Shereif H Rezkalla
Journal:  Clin Med Res       Date:  2003-10

4.  25-year-old man with flank pain, hematuria, and proteinuria.

Authors:  Andrew Smyth; Vesna D Garovic
Journal:  Mayo Clin Proc       Date:  2009       Impact factor: 7.616

5.  Contrast-Induced Acute Kidney Injury in Radiologic Management of Acute Ischemic Stroke in the Emergency Setting.

Authors:  J W Myung; J H Kim; J Cho; I Park; H Y Kim; J H Beom
Journal:  AJNR Am J Neuroradiol       Date:  2020-03-12       Impact factor: 3.825

Review 6.  Contrast medium induced acute kidney injury: a narrative review.

Authors:  Valentina Pistolesi; Giuseppe Regolisti; Santo Morabito; Ilaria Gandolfini; Silvia Corrado; Giovanni Piotti; Enrico Fiaccadori
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

7.  The incidence of contrast-induced nephropathy (CIN) following transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC).

Authors:  Katsumi Hayakawa; Masato Tanikake; Toshihiko Kirishima; Naomi Yoshinami; Hiroyuki Shintani; Eiji Yamamoto; Taisuke Morimoto
Journal:  Eur Radiol       Date:  2014-02-13       Impact factor: 5.315

8.  Atrial natriuretic peptide for the prevention of contrast-induced nephropathy: what's old is new but at the right dose and duration of therapy!

Authors:  Horng H Chen
Journal:  J Am Coll Cardiol       Date:  2009-03-24       Impact factor: 24.094

Review 9.  Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications.

Authors:  Lincoln R Potter; Andrea R Yoder; Darcy R Flora; Laura K Antos; Deborah M Dickey
Journal:  Handb Exp Pharmacol       Date:  2009

10.  Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis.

Authors:  Nilesh Lodhia; Michael Kader; Thalia Mayes; Parvez Mantry; Benedict Maliakkal
Journal:  World J Gastroenterol       Date:  2009-03-28       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.